SecBot SecBot
PRESS-RELEASE ·Filed Mar 23, 2026

VOR

Vor Biopharma
NEUTRAL
Impact 3/10
Horizonmonths Processed7mo ago WireGlobeNewswire
Press release · Activist
Actionable Insight • Neutral

Monitor insider activity and future hiring trends; no immediate financial impact, but increasing headcount may signal expansion of clinical development efforts.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$12.15
T+0 close · Mar 23, 2026 · via day close
Latest settled
+19.26%
T+60 · $14.49
Vs SPY
+4.94%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 24 $12.15entry
  2. T+1 · 8mo ago +6.50%α +5.94% · $12.94
  3. T+5 · 8mo ago +46.83%α +47.25% · $17.84
  4. T+20 · 7mo ago +26.09%α +17.19% · $15.32
  5. T+60 · 5mo ago +19.26%α +4.94% · $14.49
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Vor Bio granted stock options and RSUs to 8 new employees as inducement awards under its 2023 Inducement Plan. The awards cover 215,700 stock options and 46,235 RSUs, with exercise prices ranging from $7.95 to $24.11 per share, reflecting market closing prices on grant dates.

Key Facts

  • Granted stock options for 215,700 shares and RSUs for 46,235 shares to 8 new employees
  • Awards made in November 2025 and March 23, 2026 under Nasdaq Listing Rule 5635(c)(4) as material inducements
  • Stock options have 10-year term, exercise price equals closing price on grant date ($7.95–$24.11)
  • Options and RSUs vest over four years: 25% after 12 months, remainder monthly (options) or quarterly (RSUs)
  • No financial performance data, revenue, or clinical updates included

Financial Impact

Minimal near-term financial impact; potential future dilution of ~0.5% based on ~261,935 total shares granted and $500M market cap

dilutionshare_count

Risk Factors

  • Future dilution from vesting of options and RSUs
  • No performance-based vesting terms disclosed, compensation is time-vested only

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3260855

Track record

17 reports on VOR

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +70.35% at T+60 after the Jun 8, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $18.97 Now $18.97 −0.00% settles Nov 18
  2. Nov 12, 20264d ago 8-K Neutral 5/10 Entry $19.32 to $19.42 Now $18.97 −1.81% ▲ +0.52% +0.88% vs SPY
  3. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $18.66 to $19.88 Now $18.97 +1.66% ▲ +6.54% +6.23% vs SPY
  4. Oct 30, 202617d ago 424B5 Bearish 4/10 Entry $19.68 to $19.25 Now $18.97 +3.61% ▲ +2.19% +1.71% vs SPY
  5. Oct 30, 202617d ago Press Release Neutral 4/10 Entry $19.68 to $19.25 Now $18.97 −3.61% ▼ −2.19% −1.71% vs SPY
  6. Oct 22, 202625d ago Press Release Bullish 7/10 Entry $18.26 to $18.33 Now $18.97 +3.89% ▲ +0.38% −0.33% vs SPY
  7. Oct 5, 20266w ago Press Release Neutral 2/10 Entry $18.31 to $18.78 Now $18.97 +3.60% ▲ +2.57% +2.81% vs SPY
  8. Sep 29, 20266w ago Press Release Bullish 6/10 Entry $18.33 to $19.08 Now $18.97 +3.49% ▲ +4.09% +4.30% vs SPY
  9. Aug 11, 202613w ago Press Release Neutral 3/10 Entry $23.37 to $22.34 Now $18.97 −18.83% ▼ −4.41% −4.66% vs SPY
  10. Jul 9, 202618w ago 3 Neutral 2/10 Entry $19.14 to $18.03 Now $18.97 −0.89% ▼ −5.80% −5.03% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 23, 2026